KAT6A-IN-1, identified by its CAS number 2991087-72-8, is a small molecule inhibitor that targets the KAT6A protein, which is a member of the lysine acetyltransferase family. This compound is primarily researched for its potential role in cancer therapy, particularly in the context of tumors that exhibit dysregulation of acetylation processes. KAT6A is involved in various cellular functions, including gene expression regulation and chromatin remodeling, making its inhibition a point of interest in therapeutic strategies. The characteristics of KAT6A-IN-1 include its molecular structure, which typically features specific functional groups that facilitate its interaction with the KAT6A enzyme. Additionally, it is important to consider its solubility, stability, and bioavailability, which are critical for its efficacy as a therapeutic agent. Research into KAT6A-IN-1 is ongoing, focusing on its pharmacodynamics, pharmacokinetics, and potential side effects, as well as its effectiveness in preclinical and clinical settings.

KAT6A-IN-1

2991087-72-8: KAT6A-IN-1, identified by its CAS number 2991087-72-8, is a small molecule inhibitor that targets the KAT6A protein, which is a member of the lysine acetyltransferase family. This compound is primarily researched for its potential role in cancer therapy, particularly in the context of tumors that exhibit dysregulation of acetylation processes. KAT6A is involved in various cellular functions, including gene expression regulation and chromatin remodeling, making its inhibition a point of interest in therapeutic strategies. The characteristics of KAT6A-IN-1 include its molecular structure, which typically features specific functional groups that facilitate its interaction with the KAT6A enzyme. Additionally, it is important to consider its solubility, stability, and bioavailability, which are critical for its efficacy as a therapeutic agent. Research into KAT6A-IN-1 is ongoing, focusing on its pharmacodynamics, pharmacokinetics, and potential side effects, as well as its effectiveness in preclinical and clinical settings.

<p>KAT6A-IN-1 (compound 5) is an inhibitor of KAT6A.</p>

CAS 2991087-72-8

KAT6A-IN-1

KAT6A-IN-1

Ref: TM-T201223